Gabriel Torres

Suggest Changes
Learn More
Data on nonnucleoside reverse transcriptase inhibitors presented at the Vancouver conference is provided. Unexpectedly strong antiretroviral effects were found for 1592U89 succinate, a guanosine(More)
New data on a study, sponsored by Bristol-Myers Squibb (BMS), showed beneficial effects of d4T in patients with prolonged previous treatment with AZT. d4T (also known as stavudine or Zerit) was(More)
An extended follow-up of four European/Australian randomized trials of AZT in asymptomatic HIV-positive patients revealed that there was no overall benefit in starting AZT monotherapy immediately(More)